You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ENGN Buy Disclosure
Grossman William · SEC Form 4 · Filed Sep 24, 2026
Buy
Calculated transaction value
$10.05K
Grossman William Interim Chief Medical Officer
ENGN
Transaction date
Sep 22, 2026
Public filing date
Sep 24, 2026
Filing lag
Filed 2 days later
ENGN daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Shares
- Quantity / price
- 5,102 shares @ $1.97
- SEC ownership
- Direct
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001552781-26-000501
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$10.05K
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Engene Therapeutics Inc. ENGN Current | Buy | Sep 22, 2026 | $10.05K |